CBD Reduced Some Immune Cells in Rats but Spared Natural Killer Cells | Research

The takeaway

Repeated CBD treatment in rats reduced T cells, B cells, and total white blood cells at higher doses while sparing or enhancing natural killer (NK) and NKT cells involved in antiviral and antitumor immunity.

Read this if you take CBD and want to understand its potential effects on the immune system.

CBD reduced adaptive immune cells while sparing or enhancing innate antiviral and antitumor NK cells

What the researchers found

Male rats received daily CBD injections (2.5 or 5 mg/kg) for 14 days.

At the higher dose (5 mg/kg), CBD caused a significant decrease in total white blood cells and in the numbers of T cells, B cells, T helper cells, and T cytotoxic cells.

However, this immunosuppressive effect did not affect NK or NKT cells, which are responsible for nonspecific antiviral and antitumor immune responses.

At the lower dose (2.5 mg/kg), CBD actually increased NKT cell numbers and the percentage of NK cells.

The results suggest CBD may suppress adaptive (specific) immunity while sparing or enhancing innate (nonspecific) antiviral and antitumor defenses.

Why it matters

Understanding how CBD affects different branches of the immune system is important for evaluating its potential in autoimmune conditions (where suppressing specific immunity could help) and in cancer (where preserving NK cell function is desirable).

The numbers in context

Doses: 2.5 and 5 mg/kg daily for 14 days. At 5 mg/kg: significant decrease in total leukocytes, T cells, B cells, T helper, and T cytotoxic cells. NK and NKT cells were spared. At 2.5 mg/kg: NKT cells increased.

How the study worked

Fourteen-day repeated-dose animal study. Male Wistar rats received daily intraperitoneal CBD injections at 2.5 or 5 mg/kg or vehicle. Blood was collected one hour after the last injection. Three-color immunofluorescent staining was used to identify T, B, NK, NKT, T helper, and T cytotoxic lymphocyte subsets.

What this study cannot tell us

Rat immune systems differ from human immune systems. CBD was administered by injection, not orally. The doses and duration may not correspond to typical human CBD use. Blood sampling at a single time point may not capture the full immune response dynamics.

How to read the evidence

Animal study with intraperitoneal CBD delivery. Immune effects in rats may not translate to humans taking oral CBD.

When this study was published

Published in 2009. CBD immunology research has expanded since then, though the selective immunomodulatory profile described here has been partially supported by later studies.

The bigger picture

The selective immunomodulatory profile of CBD, suppressing adaptive immunity while sparing innate antitumor responses, could have implications for autoimmune diseases and cancer. However, translating animal immune findings to humans requires substantial caution.

Questions still open

Does oral CBD in humans produce similar selective immunomodulation? Could CBD be useful as an adjunct in autoimmune conditions? Would the preserved NK cell function translate to maintained antitumor immunity in CBD users?

Common questions

Does CBD weaken the immune system?

This rat study found CBD reduced some immune cells (T cells, B cells) at higher doses but preserved or enhanced natural killer cells involved in antiviral and antitumor defense. Whether this occurs in humans at typical CBD doses is not established.

Could this be beneficial for autoimmune conditions?

Theoretically, reducing overactive adaptive immune responses while preserving innate immunity could be beneficial in autoimmune diseases, but this hypothesis has not been adequately tested in human clinical trials.

Read the original research

Cannabidiol-induced lymphopenia does not involve NKT and NK cells.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 60 Suppl 3, 99-103

View on PubMed ↗

Citation

Ignatowska-Jankowska, B; Jankowski, M; Glac, W; Swiergel, A H. (2009). Cannabidiol-induced lymphopenia does not involve NKT and NK cells.. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 60 Suppl 3, 99-103.